The US Court of Appeals for the First Circuit has upheld class certification in the Nexium (esomeprazole magnesium) pay-for-delay case.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Nexium, antitrust, class certification, AstraZeneca, US Court of Appeals for the First Circuit
